How many institutions held ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in Q3 2023?

137 institutional investors reported ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value for Q3 2023. Use the holders table for investor-level position and value details.

Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Q: What does CUSIP 00461U105 represent in this 13F holders report?

CUSIP 00461U105 is the security identifier for ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value used to aggregate holder disclosures.

CUSIP: 00461U105

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, $0.00001 par value
Shares outstanding: 138,752,791
Total 13F shares: 70,071,814
Share change: -902,529
Total reported value: $479,974,125
Put/Call ratio: 40%
Price per share: $6.85
Number of holders: 137
Value change: -$28,113,579
Number of buys: 80
Number of sells: 48

Quarterly Holders Quick Answers

What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 00461U105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.5%	7,637,868	$79,204,691	—	30 Jun 2023	13F
BlackRock Finance, Inc.	13F	Company	4%	5,594,173	$58,011,574	—	30 Jun 2023	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.2%	4,398,453	$45,611,958	—	30 Jun 2023	13F
Rock Springs Capital Management LP	13F	Company	2.9%	3,961,849	$41,084,374	—	30 Jun 2023	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	2.5%	3,400,000	$35,258,000	—	30 Jun 2023	13F
BVF INC/IL	13F	Company	2.4%	3,360,941	$34,852,958	—	30 Jun 2023	13F
VANGUARD GROUP INC	13F	Company	2.4%	3,329,564	$34,527,578	—	30 Jun 2023	13F
BRAIDWELL LP	13F	Company	2.1%	2,901,194	$30,085,382	—	30 Jun 2023	13F
Foresite Capital Management IV, LLC	13F	Company	2%	2,808,034	$29,119,313	—	30 Jun 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.9%	2,613,074	$27,097,577	—	30 Jun 2023	13F
GREAT POINT PARTNERS LLC	13F	Company	1.4%	1,941,581	$20,134,195	—	30 Jun 2023	13F
Point72 Asset Management, L.P.	13F	Company	1.3%	1,736,500	$18,007,505	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	1.2%	1,634,815	$16,953,031	—	30 Jun 2023	13F
Holocene Advisors, LP	13F	Company	1.1%	1,485,056	$15,400,031	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	1%	1,451,984	$15,057,074	—	30 Jun 2023	13F
SAMLYN CAPITAL, LLC	13F	Company	0.97%	1,344,069	$13,937,995	—	30 Jun 2023	13F
Foresite Capital Management V, LLC	13F	Company	0.91%	1,258,243	$13,047,980	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.89%	1,237,409	$12,831,934	—	30 Jun 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.78%	1,086,620	$11,268,249	—	30 Jun 2023	13F
VR Adviser, LLC	13F	Company	0.75%	1,040,754	$10,792,619	—	30 Jun 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.72%	1,000,000	$10,370,000	—	30 Jun 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.7%	969,552	$10,054,000	—	30 Jun 2023	13F
Vivo Capital, LLC	13F	Company	0.65%	898,631	$9,318,803	—	30 Jun 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.6%	827,084	$8,576,861	—	30 Jun 2023	13F
FMR LLC	13F	Company	0.54%	748,065	$7,757,434	—	30 Jun 2023	13F
Samsara BioCapital, LLC	13F	Company	0.5%	696,171	$7,219,293	—	30 Jun 2023	13F
Verition Fund Management LLC	13F	Company	0.47%	650,927	$6,750,113	—	30 Jun 2023	13F
NORTHERN TRUST CORP	13F	Company	0.47%	649,927	$6,739,742	—	30 Jun 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.46%	636,829	$6,603,917	—	30 Jun 2023	13F
TCG Crossover Management, LLC	13F	Company	0.38%	529,839	$5,494,430	—	30 Jun 2023	13F
Logos Global Management LP	13F	Company	0.38%	525,000	$5,444,250	—	30 Jun 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.33%	454,411	$4,712,242	—	30 Jun 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.32%	444,261	$4,606,987	—	30 Jun 2023	13F
Aisling Capital Management LP	13F	Company	0.31%	434,455	$4,505,298	—	30 Jun 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.31%	426,959	$4,427,565	—	30 Jun 2023	13F
LORD, ABBETT & CO. LLC	13F	Company	0.29%	398,352	$4,131,000	—	30 Jun 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.28%	389,786	$4,042,080	—	30 Jun 2023	13F
HighTower Advisors, LLC	13F	Company	0.27%	379,802	$3,939,000	—	30 Jun 2023	13F
Walleye Capital LLC	13F	Company	0.25%	341,580	$3,542,185	—	30 Jun 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.19%	264,377	$2,741,589	—	30 Jun 2023	13F
HSBC HOLDINGS PLC	13F	Company	0.18%	249,842	$2,610,776	—	30 Jun 2023	13F
Bank of New York Mellon Corp	13F	Company	0.17%	242,426	$2,513,957	—	30 Jun 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	219,229	$2,273,405	—	30 Jun 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.15%	210,837	$2,186,380	—	30 Jun 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.15%	201,417	$2,088,694	—	30 Jun 2023	13F
Ikarian Capital, LLC	13F	Company	0.14%	200,163	$2,075,690	—	30 Jun 2023	13F
Parkman Healthcare Partners LLC	13F	Company	0.14%	193,597	$2,007,601	—	30 Jun 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.11%	151,035	$1,566,233	—	30 Jun 2023	13F
Soleus Capital Management, L.P.	13F	Company	0.11%	151,000	$1,565,870	—	30 Jun 2023	13F
Man Group plc	13F	Company	0.1%	133,036	$1,379,583	—	30 Jun 2023	13F

Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) as of Q3 2023

As of 30 Sep 2023, Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 70,071,814 shares. The largest 10 holders included BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., Rock Springs Capital Management LP, Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, Foresite Capital Management IV, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 137 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

131

Q3 2023 holders

137

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.